NCT04650581 2026-04-13FINERCanadian Cancer Trials GroupPhase 3 Active not recruiting250 enrolled 13 charts
NCT04177108 2024-03-27A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast CancerHoffmann-La RochePhase 3 Completed242 enrolled 12 charts